ACUMEN PHARMACEUTICALS
Acumen is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AβOs), which Acumen believes to be a key underlying cause of Alzheimer’s disease, or AD. Acumen is currently focused on advancing a targeted immunotherapy drug candidate, ACU193, to establish proof of mechanism in early AD patients. Acumen initiated its Phase 1 clinical trial of ACU193 in the second quarter of 2021 with the objective to evaluate its safety and ... tolerability and explore its pharmacokinetics and target engagement. This trial is currently enrolling patients with mild cognitive impairment and mild dementia due to AD. ACU193 Phase 1 data intended to evaluate safety and tolerability and demonstrate clinical proof of mechanism are expected by year end 2022.
ACUMEN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
1996-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.acumenpharm.com
Total Employee:
11+
Status:
Active
Contact:
+1 6508757772
Email Addresses:
[email protected]
Total Funding:
295.1 M USD
Technology used in webpage:
IPv6 COVID-19 Gravity Forms Akamai Hosted
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Locanabio
Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
Proclara Biosciences
Proclara is pioneering a new approach to treating neurodegenerative diseases.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Acumen Pharmaceuticals
PBM Capital Group
PBM Capital Group investment in Series B - Acumen Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Acumen Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Acumen Pharmaceuticals
BlackRock
BlackRock investment in Series B - Acumen Pharmaceuticals
Sands Capital Ventures
Sands Capital Ventures investment in Series B - Acumen Pharmaceuticals
PBM Capital Group
PBM Capital Group investment in Series A - Acumen Pharmaceuticals
Sands Capital Ventures
Sands Capital Ventures investment in Series A - Acumen Pharmaceuticals
National Institute on Aging
National Institute on Aging investment in Grant - Acumen Pharmaceuticals
NeuroVentures
NeuroVentures investment in Venture Round - Acumen Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-02-01 | Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer |
Official Site Inspections
http://www.acumenpharm.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.26 K
Unable to get host informations!!!
More informations about "Acumen Pharmaceuticals"
About Us - Acumen Pharma
Our vision is to enhance health and wellness by manufacturing and delivering safe, effective, and innovative pharmaceutical products. We are committed to upholding the highest standards of …See details»
Acumen Pharmaceuticals, Inc. | LinkedIn
Acumen Pharmaceuticals, Inc. Biotechnology Research Greater Boston, MA 6,094 followers Forging a new path towards a safe and effective treatment for Alzheimer’s disease.See details»
Acumen Pharmaceuticals Org Chart + Executive Team
The org chart of Acumen Pharmaceuticals contains its 41 main executives like Daniel O'Connell, Matthew Zuga and Jim Doherty.See details»
Acumen Pharmaceuticals - Crunchbase Company …
Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.See details»
Investor Relations | Acumen Pharmaceuticals, Inc
Jul 15, 2025 The Investor Relations website contains information about Acumen Pharmaceuticals, Inc's business for stockholders, potential investors, and financial analysts.See details»
Acumen Pharmaceuticals, Inc. - Executive Bio, Top Executies, and ...
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.See details»
About Us | Acumen Pharmaceuticals
Our founders pioneered seminal discoveries and methods to understand the role of toxic soluble amyloid beta oligomers (AβOs) in synaptic dysfunction and neurodegeneration. Today, Acumen’s leaders are leveraging critical insights …See details»
Acumen Pharmaceuticals
Jun 20, 2025 Acumen was founded in 2001 by Jacqueline Novogratz, with help of seed capital from the Rockefeller Foundation, Cisco Systems Foundations and three individual …See details»
Acumen Pharmaceuticals - The Org
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta …See details»
Acumen Pharmaceuticals (ABOS) Company Profile & Description
Jul 1, 2021 Company profile for Acumen Pharmaceuticals, Inc. (ABOS) stock, with a description, list of executives, contact details and other key facts.See details»
Acumen Pharma - Craft
Oct 29, 2024 Acumen Pharma has 2 employees across 2 locations. See insights on Acumen Pharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Acumen Pharmaceuticals, Inc. Information - RocketReach
Acumen Pharmaceuticals, Inc. is a Biotechnology, Biotechnology Research, and Drug Manufacturing & Research company located in Massachusetts, US with $65.8 million in …See details»
Working At Acumen Pharma: Company Overview and Culture
Mar 14, 2024 Find out what it's like to work at Acumen Pharma. See what kind of people work at Acumen Pharma, career paths working at Acumen Pharma, company culture, salaries, …See details»
Our Team | Acumen Pharmaceuticals
Passionate. Dedicated. Life science professionals and Alzheimer’s experts. This is the Acumen team. Industry and functional experts. Our foundation is built on collective learnings—and we …See details»
Acumen Pharmaceuticals, Inc. Overview - SignalHire
Organization Website acumenpharm.com Social Links Phone Number 434-297-1000 Acumen Pharmaceutica... industries Biotech, Pharmaceuticals Acumen Pharmaceutica... Employees …See details»
Acumen Pharmaceuticals Company Profile | Management and
Acumen Pharmaceuticals Profile and History Acumen is a clinical-stage biopharmaceutical company developing targeted therapies for the safe and effective treatment of Alzheimers …See details»
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial …
9 hours ago The company is headquartered in Newton, Mass. For more information, visit www.acumenpharm.com. Forward-Looking StatementsSee details»
Ask Acumen | Acumen Pharmaceuticals
In July I spent my 3 rd anniversary with Acumen. Before Acumen, I worked at Avid Radiopharmaceuticals, which created a tracer for Alzheimer’s, for 4 years.See details»
about_ | Acumen Pharmaceuticals
We value your privacy Our website and its partners store and/or access information on your device, such as unique cookie identifiers. We use third party cookies to understand how you …See details»
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial …
9 hours ago Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026Expect …See details»